II 

112TH CONGRESS 

1ST SESSION S. 2002 

To amend the Federal Food, Drug, and Cosmetic Act to improve the safety 

of Internet pharmacies. 

IN THE SENATE OF THE UNITED STATES 

DECEMBER 15, 2011 

Mrs. FEINSTEIN (for herself, Mr. SESSIONS, Mr. SCHUMER, and Mr. CORNYN) 

introduced the following bill; which was read twice and referred to the 

Committee on Health, Education, Labor, and Pensions 

A BILL 

To amend the Federal Food, Drug, and Cosmetic Act to 

improve the safety of Internet pharmacies. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Online Pharmacy Safe5 ty Act’’. 

6 SEC. 2. FINDINGS. 

7 Congress finds that— 

8 (1) consumers in the United States are targeted 

9 by organized international crime networks that use 

10 Internet websites to sell illegal and often dangerous 


sroberts on DSK5SPTVN1PROD with BILLS
2 

•S 2002 IS

1 drugs under the guise of being legitimate online 

2 pharmacies; 

3 (2) illegal online drug sellers offer products that 

4 do not meet the safety standards established by 

5 United States laws, and recent reports from the Na6 tional Association of Boards of Pharmacy show that 

7 92 to 95 percent of Internet websites offering to sell 

8 prescription medications online are illegitimate and 

9 operate in clear violation of United States laws en10 acted to protect patients; 

11 (3) criminals are attracted to the high profit 

12 margin of business through illegitimate online drug 

13 sales, as counterfeit drug sales alone are estimated 

14 to have generated $75,000,000,000 in 2010, an in15 crease of 92 percent from 2005; 

16 (4) the World Health Organization estimates 

17 that 50 percent of the prescription medicines sold 

18 online by Internet websites that hide their physical 

19 address are counterfeit; 

20 (5) research by The Partnership at 

21 Drugfree.org found that 1 in 6 consumers in the 

22 United States, a total of about 36,000,000 Ameri23 cans, has bought or currently buys prescription 

24 medication online without a valid prescription; 


sroberts on DSK5SPTVN1PROD with BILLS
3 

•S 2002 IS

1 (6) the prevalence of illegal online drug sellers, 

2 and their sale of counterfeit or otherwise illegitimate 

3 medicines, is a growing public health threat; 

4 (7) people have been seriously injured or killed 

5 by products sold by illegal online drug sellers; 

6 (8) the accessibility of controlled substances 

7 and other drugs without a valid prescription by ille8 gal online drug sellers contributes to a growing pre9 scription drug abuse problem in the United States 

10 that is endangering teenagers and public health; 

11 (9) the anonymous and unregulated nature of 

12 the Internet contributes to the counterfeit drug 

13 trade and enables counterfeit medicines to reach 

14 United States consumers through illegitimate online 

15 drug sellers posing as legitimate pharmacies; 

16 (10) counterfeit drugs that are sold through il17 legal online drug sellers are manufactured by crimi18 nals who deliberately and fraudulently misrepresent 

19 the product in order to trick consumers into think20 ing they are purchasing a legitimate and safe medi21 cine; 

22 (11) these counterfeit drugs are frequently 

23 manufactured in unsanitary conditions and may con24 tain the wrong ingredients, lack active ingredients, 


sroberts on DSK5SPTVN1PROD with BILLS
4 

•S 2002 IS

1 have insufficient or contaminated active ingredients, 

2 or contain too many active ingredients; 

3 (12) counterfeit drugs obtained from illegal on4 line drug sellers have been found to contain harmful 

5 ingredients including arsenic, boric acid, brick dust, 

6 cement powder, chalk dust, floor polish, leaded road 

7 paint, nickel, shoe polish, and talcum powder; 

8 (13) United States citizens deserve access to 

9 safe and legitimate online pharmacies and protection 

10 from illegal Internet websites that sell counterfeit or 

11 otherwise illegitimate medication; 

12 (14) while the Ryan Haight Online Pharmacy 

13 Consumer Protection Act of 2008 (Public Law 110– 

14 425) has helped to prevent illegitimate online sales 

15 of prescribed controlled substances, illegal online 

16 sellers continue to sell other types of prescription 

17 drugs and stronger laws are needed to stop them; 

18 and 

19 (15) greater education and awareness regarding 

20 illegal online drug sellers will help to protect the 

21 United States drug supply chain from infiltration by 

22 unregulated and counterfeit products. 

23 SEC. 3. VALID PRESCRIPTIONS. 

24 Section 503(b) of the Federal Food, Drug, and Cos25 metic Act (21 U.S.C. 353(b)) is amended— 


sroberts on DSK5SPTVN1PROD with BILLS
5 

•S 2002 IS

1 (1) in paragraph (1), in the matter following 

2 subparagraph (B), by striking ‘‘shall be dispensed’’ 

3 and all that follows through ‘‘the pharmacist.’’ and 

4 inserting the following: ‘‘shall be dispensed only pur5 suant to a valid prescription that is (i) a written 

6 prescription of a practitioner licensed by law to ad7 minister such drug; (ii) an oral prescription of such 

8 practitioner which is reduced promptly to writing by 

9 the pharmacist; (iii) an electronic prescription issued 

10 by a practitioner licensed by law to administer such 

11 drug; or (iv) the refill of any such written, oral, or 

12 electronic prescription if such refilling is authorized 

13 by the prescriber either in the original prescription, 

14 electronic prescription, or by oral order which is re15 duced promptly to writing by the pharmacist.’’; and 

16 (2) by adding at the end the following: 

17 ‘‘(6) In this paragraph: 

18 ‘‘(A) The term ‘valid prescription’ means a 

19 prescription that is issued for a legitimate med20 ical purpose in the usual course of professional 

21 practice by— 

22 ‘‘(i) a licensed practitioner who has 

23 conducted at least 1 in-person medical 

24 evaluation of the patient, subject to para25 graph (7); 


sroberts on DSK5SPTVN1PROD with BILLS
6 

•S 2002 IS

1 ‘‘(ii) a covering practitioner; or 

2 ‘‘(iii) a practitioner engaged in the 

3 practice of telemedicine. 

4 ‘‘(B)(i) The term ‘in-person medical eval5 uation’ means a medical evaluation that is con6 ducted with the patient in the physical presence 

7 of the practitioner, without regard to whether 

8 portions of the evaluation are conducted by 

9 other health professionals. 

10 ‘‘(ii) Nothing in clause (i) shall be con11 strued to imply that 1 in-person medical evalua12 tion demonstrates that a prescription has been 

13 issued for a legitimate medical purpose within 

14 the usual course of professional practice. 

15 ‘‘(C) The term ‘covering practitioner’ 

16 means, with respect to a patient, a licensed 

17 practitioner who conducts a medical evaluation 

18 (other than an in-person medical evaluation) at 

19 the request of a licensed practitioner who— 

20 ‘‘(i) has conducted at least 1 in-per21 son medical evaluation of the patient or an 

22 evaluation of the patient through the prac23 tice of telemedicine, within the previous 24 

24 months; and 


sroberts on DSK5SPTVN1PROD with BILLS
7 

•S 2002 IS

1 ‘‘(ii) is temporarily unavailable to con2 duct the evaluation of the patient. 

3 ‘‘(D) The term ‘practice of telemedicine’ 

4 has the meaning given that term in section 102 

5 of the Controlled Substances Act. 

6 ‘‘(7) For purposes of paragraph (6), an in-per7 son medical evaluation of the patient is not required 

8 if— 

9 ‘‘(A) the prescribing practitioner is issuing 

10 a prescription or dispensing a legend drug in 

11 accordance with the Expedited Partner Therapy 

12 in the Management of Sexually Transmitted 

13 Diseases guidance document issued by the Cen14 ters for Disease Control and Prevention; or 

15 ‘‘(B) the prescription, administration, or 

16 dispensing is through a public health clinic or 

17 other distribution mechanism approved by the 

18 State health authority in order to prevent, miti19 gate, or treat a pandemic illness, infectious dis20 ease outbreak, or intentional or accidental re21 lease of a biological, chemical, or radiological 

22 agent. 

23 ‘‘(8) The Secretary may by regulation establish 

24 exceptions to the requirements described in paraVerDate Mar 15 2010 20:58 Dec 22, 2011 Jkt 019200 PO 00000 Frm 00007 Fmt 6652 Sfmt 6201 E:\BILLS\S2002.IS S2002

sroberts on DSK5SPTVN1PROD with BILLS
8 

•S 2002 IS

1 graph (6) with respect to a drug, based on criteria 

2 established by the Secretary.’’. 

3 SEC. 4. REGISTRY OF LEGITIMATE ONLINE PHARMACY 

4 WEBSITES. 

5 Chapter V of the Federal Food, Drug, and Cosmetic 

6 Act (21 U.S.C. 351 et seq.) is amended by inserting after 

7 section 510 the following: 

8 ‘‘SEC. 510A. REGISTRY OF LEGITIMATE ONLINE PHARMACY 

9 WEBSITES. 

10 ‘‘(a) DEFINITIONS.—In this section: 

11 ‘‘(1) DISPENSING PHARMACY.—The term ‘dis12 pensing pharmacy’ means a pharmacy that dis13 penses, distributes, or supplies prescription drugs 

14 pursuant to orders made on, through, or on behalf 

15 of, an online pharmacy website. 

16 ‘‘(2) DOMAIN NAME.—The term ‘domain name’ 

17 has the meaning given that term in section 45 of the 

18 Lanham Act (15 U.S.C. 1127). 

19 ‘‘(3) FINANCIAL TRANSACTION PROVIDER.— 

20 The term ‘financial transaction provider’ has the 

21 meaning given that term in section 5362(4) of title 

22 31, United States Code. 

23 ‘‘(4) INTERNET WEBSITE.—The term ‘Internet 

24 website’ means the collection of digital assets, in25 cluding links, indexes, or pointers to digital assets, 


sroberts on DSK5SPTVN1PROD with BILLS
9 

•S 2002 IS

1 accessible through the Internet that are addressed 

2 relative to a common domain name. 

3 ‘‘(5) LEGITIMATE ONLINE PHARMACY

4 WEBSITE.—The term ‘legitimate online pharmacy 

5 website’ means an online pharmacy website that is 

6 included in the Registry pursuant to a designation 

7 by the Secretary under this section. 

8 ‘‘(6) ONLINE PHARMACY WEBSITE.—The term 

9 ‘online pharmacy website’ means an Internet website 

10 that offers, sells, dispenses, or distributes, or facili11 tates the sale, dispensing, or distribution of prescrip12 tion or other drugs to consumers. 

13 ‘‘(7) PRESCRIPTION DRUG.—The term ‘pre14 scription drug’ means a drug that is subject to sec15 tion 503(b)(1). 

16 ‘‘(b) ESTABLISHMENT OF REGISTRY.—The Secretary 

17 shall establish a Registry of Legitimate Online Pharmacy 

18 Websites (referred to in this section as the ‘Registry’) for 

19 the purpose of educating consumers and promoting public 

20 health and safety. 

21 ‘‘(c) CRITERIA.—The Secretary shall designate an 

22 online pharmacy website as a legitimate online pharmacy 

23 website, and include such legitimate online pharmacy 

24 website on the Registry, if the Secretary determines 

25 that— 


sroberts on DSK5SPTVN1PROD with BILLS
10 

•S 2002 IS

1 ‘‘(1) the online pharmacy website is accredited 

2 by the United States National Association of Boards 

3 of Pharmacy Verified Internet Pharmacy Practice 

4 Sites program; or 

5 ‘‘(2) the online pharmacy website meets each of 

6 the following requirements: 

7 ‘‘(A) Prescription drugs ordered, sold, dis8 pensed, distributed, supplied, or provided 

9 through or by the online pharmacy website are 

10 sold, dispensed, distributed, supplied, or pro11 vided solely by dispensing pharmacies that are 

12 domiciled in the United States and that main13 tain pharmacy licensure, a permit, or registra14 tion in good standing in all United States juris15 dictions where such dispensing pharmacies pro16 vide services or are required to maintain such 

17 licensure, permit, or registration. 

18 ‘‘(B) Each dispensing pharmacy affiliated 

19 with, or that dispenses, distributes, supplies, or 

20 provides prescription or other drugs on behalf 

21 of the online pharmacy website, maintains a 

22 valid Drug Enforcement Administration reg23 istration, unless such registration is not re24 quired by Drug Enforcement Administration 

25 regulations. 


sroberts on DSK5SPTVN1PROD with BILLS
11 

•S 2002 IS

1 ‘‘(C) Each dispensing pharmacy affiliated 

2 with, or that dispenses, distributes, supplies, or 

3 provides prescription drugs on behalf of the on4 line pharmacy website, dispenses, distributes, 

5 supplies, provides, or offers or attempts to dis6 pense, distribute, supply, or provide, prescrip7 tion drugs only pursuant to a valid prescription 

8 (as defined in section 503(b)). 

9 ‘‘(D) Each dispensing pharmacy affiliated 

10 with, or that dispenses, distributes, supplies, or 

11 provides prescription drugs on behalf of the on12 line pharmacy website, complies with applicable 

13 Federal and State laws and regulations applica14 ble to pharmacy practice. 

15 ‘‘(E) Each dispensing pharmacy affiliated 

16 with, or that dispenses, distributes, supplies, or 

17 provides prescription or other drugs on behalf 

18 of the online pharmacy website, does not dis19 pense, distribute, supply, provide, offer or at20 tempt to dispense, distribute, supply, or pro21 vide, advertise, or promote prescription or other 

22 drugs that have not been approved by the Food 

23 and Drug Administration. 

24 ‘‘(F) The online pharmacy website promi25 nently displays the following information: 


sroberts on DSK5SPTVN1PROD with BILLS
12 

•S 2002 IS

1 ‘‘(i) An accurate United States street 

2 address of each dispensing pharmacy or 

3 the corporate or other legal business entity 

4 headquarters of each dispensing pharmacy. 

5 ‘‘(ii) An accurate, readily accessible, 

6 and responsive telephone number or other 

7 secure accurate means that allows the con8 sumer to contact or consult with the phar9 macist about his or her prescription drug. 

10 ‘‘(G) The online pharmacy website does 

11 not make any statements, regarding the nature 

12 of any dispensing pharmacy or product offered 

13 via the website, that are materially misleading 

14 or fraudulent. 

15 ‘‘(H) The domain name registration infor16 mation applicable to the online pharmacy 

17 website is accurate, not anonymous, and has a 

18 logical nexus to each dispensing pharmacy or 

19 the corporate or other legal business head20 quarters of each dispensing pharmacy. 

21 ‘‘(I) The online pharmacy website, includ22 ing any operator, content owner, or domain 

23 name registrant of the online pharmacy website, 

24 is not affiliated with, and does not own or conVerDate Mar 15 2010 20:58 Dec 22, 2011 Jkt 019200 PO 00000 Frm 00012 Fmt 6652 Sfmt 6201 E:\BILLS\S2002.IS S2002

sroberts on DSK5SPTVN1PROD with BILLS
13 

•S 2002 IS

1 trol any other online pharmacy website that vio2 lates the requirements under this paragraph. 

3 ‘‘(J) The online pharmacy website, includ4 ing any operator, content owner, or domain 

5 name registrant of the online pharmacy website, 

6 is not affiliated with, and does not own or con7 trol any other online pharmacy website that vio8 lates Federal or State law. 

9 ‘‘(K) Information that would be considered 

10 protected health information under the regula11 tions promulgated under section 264(c) of the 

12 Health Insurance Portability and Accountability 

13 Act of 1996 (commonly referred to as the 

14 ‘HIPAA Privacy Rule’) is transmitted by the 

15 online pharmacy website and each dispensing 

16 pharmacy affiliated with, or that dispenses, dis17 tributes, supplies, or provides prescription 

18 drugs on behalf of the online pharmacy website, 

19 in accordance with the requirements of such 

20 Act, including the use of Secure-Socket Layer 

21 or equivalent technology for the transmission of 

22 protected health information, and the online 

23 pharmacy website displays its privacy policy 

24 and that such policy complies with the require25 ments of the HIPAA Privacy Rule. 


sroberts on DSK5SPTVN1PROD with BILLS
14 

•S 2002 IS

1 ‘‘(L) The online pharmacy website com2 plies with other requirements as determined ap3 propriate by the Secretary, in consultation with 

4 other Federal and State agencies responsible 

5 for regulating the practice of pharmacy. 

6 ‘‘(d) PROCESS.— 

7 ‘‘(1) APPLICATION.—The Secretary shall de8 velop an application process through which an inter9 ested operator, content owner, or domain name reg10 istrant of an online pharmacy website may apply for 

11 inclusion on the Registry. Such an application shall 

12 be submitted in such form and manner as required 

13 by the Secretary and shall include, at a minimum, 

14 information to determine whether the online phar15 macy website satisfies the criteria described under 

16 subsection (c). The Secretary shall not charge a fee 

17 for submission of an application. 

18 ‘‘(2) IDENTIFICATION WITHOUT APPLICA19 TION.— 

20 ‘‘(A) IN GENERAL.—The Secretary shall 

21 take reasonable steps to identify online phar22 macy websites for which no application has 

23 been submitted under paragraph (1) and evalu24 ate whether these online pharmacy websites sat25 isfy the criteria described under subsection (c). 


sroberts on DSK5SPTVN1PROD with BILLS
15 

•S 2002 IS

1 ‘‘(B) COMPLIANCE CONFIRMED.—In cases 

2 where satisfaction of the criteria described 

3 under subsection (c) can be verified without the 

4 receipt of an application, an online pharmacy 

5 website that the Secretary determines to satisfy 

6 such criteria may be designated as a legitimate 

7 online pharmacy website and included on the 

8 Registry and the operator, content owner, or 

9 domain name registrant of such online phar10 macy website shall be notified of such place11 ment. 

12 ‘‘(C) ADDITIONAL INFORMATION RE13 QUIRED.—In cases where satisfaction of the cri14 teria described under subsection (c) cannot be 

15 verified without additional information or some 

16 corrective action by the online pharmacy 

17 website operator, content owner, or domain 

18 name registrant, the online pharmacy website 

19 shall not be designated as a legitimate online 

20 pharmacy website or placed on the Registry 

21 until the additional information is received by 

22 the Secretary and the Secretary determines that 

23 all applicable and necessary corrective actions 

24 have been taken. 


sroberts on DSK5SPTVN1PROD with BILLS
16 

•S 2002 IS

1 ‘‘(3) REGULATIONS REGARDING APPLICATION

2 PROCESS.— 

3 ‘‘(A) IN GENERAL.—The Secretary shall 

4 promulgate regulations— 

5 ‘‘(i) to establish the timeframes appli6 cable to informing online pharmacy website 

7 operators, content owners, or domain name 

8 registrants that submit an application 

9 under paragraph (1) of the acceptance or 

10 denial of such application; 

11 ‘‘(ii) to address what information may 

12 be shared with or withheld from online 

13 pharmacy website operators, content own14 ers, or domain name registrants that sub15 mit such an application regarding correc16 tive actions that would need to be taken to 

17 establish compliance with the Registry re18 quirements; 

19 ‘‘(iii) to establish an appeal process 

20 giving online pharmacy website operators, 

21 content owners, or domain name reg22 istrants that submit such an application 

23 the ability to request a second review of 

24 the application to determine compliance 

25 with the Registry requirements; and 


sroberts on DSK5SPTVN1PROD with BILLS
17 

•S 2002 IS

1 ‘‘(iv) to address other procedural mat2 ters regarding the receipt and evaluation of 

3 applications submitted under paragraph 

4 (1) as the Secretary determines necessary. 

5 ‘‘(B) LIMITATION REGARDING APPEALS

6 PROCESS.—The appeals process established 

7 under subparagraph (A)(iii) shall in no case re8 quire the Secretary— 

9 ‘‘(i) to disclose information that may 

10 impede an ongoing or potential criminal or 

11 regulatory investigation; or 

12 ‘‘(ii) to provide an opportunity for ap13 peal in cases where the Secretary deter14 mines, in the Secretary’s sole discretion, 

15 that the violation of a Registry require16 ment is materially significant, such a viola17 tion is not likely to be curable, or the ap18 plicant has engaged in a pattern of viola19 tions of Federal or State law. 

20 ‘‘(4) AUTHORITY AND PROCESS FOR REMOVAL

21 FROM REGISTRY.— 

22 ‘‘(A) IN GENERAL.—The Secretary shall 

23 have the authority to remove an online phar24 macy website from the Registry— 


sroberts on DSK5SPTVN1PROD with BILLS
18 

•S 2002 IS

1 ‘‘(i) upon determination that the on2 line pharmacy website is not in compliance 

3 with the criteria as established by this sec4 tion; 

5 ‘‘(ii) upon determination that the on6 line pharmacy website was mistakenly in7 cluded in the Registry; or 

8 ‘‘(iii) for good cause as determined by 

9 the Secretary based on credible evidence. 

10 ‘‘(B) PROCESS.—If the Secretary deter11 mines that an online pharmacy website shall be 

12 removed from the Registry under subparagraph 

13 (A), the Secretary shall provide notice to the 

14 operator, content owner, or domain name reg15 istrant of the online pharmacy website of the 

16 determination, the date of the removal of the 

17 website from the Registry, and the reasons for 

18 removal. 

19 ‘‘(C) REGULATIONS FOR APPEAL PROC20 ESS.— 

21 ‘‘(i) IN GENERAL.—The Secretary 

22 shall promulgate regulations that provide 

23 the operator, content owner, or domain 

24 name registrant of an online pharmacy 

25 website removed from the Registry the 


sroberts on DSK5SPTVN1PROD with BILLS
19 

•S 2002 IS

1 ability to appeal the removal and to pro2 vide information to correct matters that 

3 served as basis for removal from the Reg4 istry. Such regulations shall provide a rea5 sonable time period to correct the grounds 

6 for removal. 

7 ‘‘(ii) LIMITATION REGARDING AP8 PEALS PROCESS.—The appeals process es9 tablished under clause (i) shall in no case 

10 require the Secretary— 

11 ‘‘(I) to disclose information that 

12 may impede an ongoing or potential 

13 criminal or regulatory investigation; 

14 or 

15 ‘‘(II) to provide an opportunity 

16 for appeal in cases where the Sec17 retary determines, in the Secretary’s 

18 sole discretion, that the violation of a 

19 Registry requirement is materially sig20 nificant, such a violation is not likely 

21 to be curable, or the applicant has en22 gaged in a pattern of violations of 

23 Federal or State law. 

24 ‘‘(e) CONTRACTS WITH PRIVATE ENTITIES.— 


sroberts on DSK5SPTVN1PROD with BILLS
20 

•S 2002 IS

1 ‘‘(1) IN GENERAL.—The Secretary may enter 

2 into contracts with the United States National Asso3 ciation of Boards of Pharmacy or other private enti4 ties to— 

5 ‘‘(A) review applications submitted under 

6 subsection (d)(1) and evaluate whether the on7 line pharmacy website satisfies the criteria de8 scribed under subsection (c); 

9 ‘‘(B) on an ongoing basis, review and iden10 tify online pharmacy websites for which no ap11 plication has been submitted under subsection 

12 (d)(1) and evaluate whether these online phar13 macies satisfy the criteria described under sub14 section (c); 

15 ‘‘(C) make recommendations to the Sec16 retary as to whether an online pharmacy 

17 website, either through application or through 

18 identification under subparagraph (B), satisfies 

19 the criteria under subsection (c); 

20 ‘‘(D) notify the Food and Drug Adminis21 tration of online pharmacy websites that do not 

22 to satisfy such criteria; and 

23 ‘‘(E) provide services to maintain the Reg24 istry. 


sroberts on DSK5SPTVN1PROD with BILLS
21 

•S 2002 IS

1 ‘‘(2) CONTRACTING.—In contracting with enti2 ties under this subsection, the Secretary— 

3 ‘‘(A) may waive such provisions of the 

4 Federal Acquisition Regulation, except for pro5 visions relating to confidentiality of informa6 tion, as necessary for the efficient implementa7 tion of this subsection and for selecting such 

8 entities; and 

9 ‘‘(B) shall select entities that have dem10 onstrated a history of competency in reviewing, 

11 evaluating, and determining the legitimacy of 

12 online pharmacy websites, based on standards 

13 approved by the United States National Asso14 ciation of Boards of Pharmacy. 

15 ‘‘(3) TERMS OF CONTRACT.—A contract with 

16 an entity under this subsection shall include such 

17 terms and conditions as specified by the Secretary, 

18 including the following: 

19 ‘‘(A) The entity shall monitor the Internet 

20 on an ongoing basis in order to sufficiently 

21 maintain a current list of legitimate online 

22 pharmacy websites for consideration by the Sec23 retary. 

24 ‘‘(B) On at least a monthly basis, the enti25 ty shall submit to the Secretary an updated list 


sroberts on DSK5SPTVN1PROD with BILLS
22 

•S 2002 IS

1 of legitimate online pharmacy websites rec2 ommended for inclusion on the Registry. 

3 ‘‘(f) USE OF REGISTRY.— 

4 ‘‘(1) PUBLIC AVAILABILITY.—The Secretary 

5 shall— 

6 ‘‘(A) make the Registry available to Inter7 net advertising services, financial transaction 

8 providers, domain name registries, domain 

9 name registrars, other domain name authori10 ties, information location tool service providers, 

11 and others as determined necessary and appro12 priate by the Secretary to promote public health 

13 and safety; 

14 ‘‘(B) make the Registry available to con15 sumers and other interested persons through 

16 publication on the Internet website of the Food 

17 and Drug Administration; and 

18 ‘‘(C) specify the Registry criteria used to 

19 designate legitimate online pharmacy websites 

20 on the Internet website of the Food and Drug 

21 Administration. 

22 ‘‘(2) CONSUMER EDUCATION.—The Secretary 

23 shall— 

24 ‘‘(A) engage in a campaign to educate con25 sumers on the availability and use of the RegVerDate Mar 15 2010 20:58 Dec 22, 2011 Jkt 019200 PO 00000 Frm 00022 Fmt 6652 Sfmt 6201 E:\BILLS\S2002.IS S2002

sroberts on DSK5SPTVN1PROD with BILLS
23 

•S 2002 IS

1 istry to promote public health and safety 

2 through means as determined appropriate and 

3 necessary by the Secretary, which may include 

4 radio, television, print media, and Internet pub5 lic service announcements; and 

6 ‘‘(B) make consumer education materials 

7 available, on the Internet website of the Food 

8 and Drug Administration and in a consumer9 friendly form and manner, regarding how to 

10 safely purchase drugs over the Internet. 

11 ‘‘(g) REFUSAL OF SERVICE; IMMUNITY.— 

12 ‘‘(1) REFUSAL OF SERVICE.—A domain name 

13 registry, domain name registrar, other domain name 

14 authority, financial transaction provider, information 

15 location tool service provider, or Internet advertising 

16 service, acting in good faith based on the Registry, 

17 may cease or refuse to provide services to an online 

18 pharmacy website that is not included on the Reg19 istry. 

20 ‘‘(2) IMMUNITY FROM LIABILITY.—An entity 

21 described in paragraph (1), including the directors, 

22 officers, employees, or agents of such entity, that, 

23 acting in good faith, ceases or refuses to provide 

24 services to an online pharmacy website that is not 


sroberts on DSK5SPTVN1PROD with BILLS
24 

•S 2002 IS

1 listed on the Registry shall not be liable to any party 

2 under any Federal or State law for such action. 

3 ‘‘(3) IMMUNITY FROM SUIT.—No cause of ac4 tion shall lie in any court or administrative agency 

5 against any entity described in paragraph (1), in6 cluding the directors, officers, employees, or agents 

7 of such entity, that, acting in good faith, ceases or 

8 refuses to provide services to an online pharmacy 

9 website that is not included on the Registry.’’. 

10 SEC. 5. FUNDING. 

11 There is authorized to be appropriated such sums as 

12 may be necessary to carry out this Act (and the amend13 ments made by this Act). 

14 SEC. 6. EFFECTIVE DATE. 

15 This Act (and the amendments made by this Act) 

16 shall take effect on the date that is 180 days after the 

17 date of enactment of this Act. 

Æ 


sroberts on DSK5SPTVN1PROD with BILLS